DD March 10, 2011..
InfuSystem Holdings, Inc. Acquires Star Infusion
MADISON HEIGHTS, Mich., March 10, 2011 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE Amex:INFU), the leading national provider of infusion pumps and related services, announced today that it has acquired Michigan-based Star Infusion and Compression Therapies LLC ("Star Infusion"). Star Infusion is a provider of ambulatory infusion pumps and related services to oncologists in Michigan and Ohio.
Sean McDevitt, Chairman and CEO of InfuSystem, said, "Star Infusion has developed a loyal customer following and we welcome those oncology practices and their patients to InfuSystem. We are very pleased with the synergies this acquisition provides and it further solidifies and enhances InfuSystem's leading national position in the ambulatory infusion market."
The acquisition, which was for cash, is not expected to materially impact the Company's fiscal 2011 consolidated financial performance. Further details of the acquisition were not disclosed.
About InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc. is the leading provider of infusion pumps and related services to hospitals, oncology practices and other alternate site healthcare providers. Headquartered in Madison Heights, Michigan, the company delivers local, field-based customer support, and also operates Centers of Excellence in Michigan, Kansas, California, and Ontario, Canada. The company's stock is traded on the NYSE Amex under the symbol INFU.
Additional information about InfuSystem Holdings, Inc. is available at www.infusystem.com.
CONTACT: Investor Contact:
Pat LaVecchia
Vice Chairman
Info@InfuSystem.com
800-962-9656
Source: InfuSystem, Inc.
InfuSystem Holdings, Inc. Acquires Star Infusion
MADISON HEIGHTS, Mich., March 10, 2011 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE Amex:INFU), the leading national provider of infusion pumps and related services, announced today that it has acquired Michigan-based Star Infusion and Compression Therapies LLC ("Star Infusion"). Star Infusion is a provider of ambulatory infusion pumps and related services to oncologists in Michigan and Ohio.
Sean McDevitt, Chairman and CEO of InfuSystem, said, "Star Infusion has developed a loyal customer following and we welcome those oncology practices and their patients to InfuSystem. We are very pleased with the synergies this acquisition provides and it further solidifies and enhances InfuSystem's leading national position in the ambulatory infusion market."
The acquisition, which was for cash, is not expected to materially impact the Company's fiscal 2011 consolidated financial performance. Further details of the acquisition were not disclosed.
About InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc. is the leading provider of infusion pumps and related services to hospitals, oncology practices and other alternate site healthcare providers. Headquartered in Madison Heights, Michigan, the company delivers local, field-based customer support, and also operates Centers of Excellence in Michigan, Kansas, California, and Ontario, Canada. The company's stock is traded on the NYSE Amex under the symbol INFU.
Additional information about InfuSystem Holdings, Inc. is available at www.infusystem.com.
CONTACT: Investor Contact:
Pat LaVecchia
Vice Chairman
Info@InfuSystem.com
800-962-9656
Source: InfuSystem, Inc.
Recent INFU News
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/10/2026 04:56:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/19/2026 12:45:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/16/2026 08:31:11 PM
- InfuSystem to Participate at 38th Annual ROTH Conference on March 23, 2026 • Business Wire • 03/16/2026 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2026 09:54:04 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/27/2026 09:07:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/24/2026 11:30:13 AM
- InfuSystem Announces Financial Results for Fourth Quarter and Full Year 2025 • Business Wire • 02/24/2026 11:30:00 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/17/2026 07:20:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 11:36:07 AM
- InfuSystem to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 • Business Wire • 02/17/2026 11:30:00 AM
- Ambulatory Infusion Pumps used in Pain Management Business by InfuSystem to Receive Separate Payment Under NOPAIN Act Starting January 1, 2026 • Business Wire • 12/10/2025 10:37:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/10/2025 10:23:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 09:30:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/10/2025 09:31:32 PM
- InfuSystem to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18, 2025 • Business Wire • 11/10/2025 09:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/04/2025 09:20:11 PM
- InfuSystem Reports Third Quarter 2025 Financial Results • Business Wire • 11/04/2025 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/04/2025 11:28:54 AM
- InfuSystem to Report Third Quarter 2025 Financial Results on November 4, 2025 • Business Wire • 10/28/2025 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/28/2025 08:08:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/06/2025 09:23:03 PM
- InfuSystem to Present at 4th Annual ROTH Healthcare Opportunities Conference on October 9, 2025 • Business Wire • 09/25/2025 08:29:00 PM
